Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0677930 (
primary tumor
)
20,210
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Epithelial-myoepithelial carcinoma (EMC) is a rare neoplasm arising predominantly in the salivary glands, in particular in the parotid gland. We report the morphological features of an epithelial-myoepithelial
carcinoma of the parotid
gland with one lymph-node metastasis including a molecular genetic study of this tumor. Immunohistochemical and ultrastructural results confirmed the epithelial-myoepithelial dualism of the carcinoma. The loss of heterozygosity (LOH) analysis revealed different LOH results for the solid and the tubular growth pattern of the
primary tumor
, but showed identical findings for the solid
primary tumor
component and the lymph node metastasis which had also a solid appearance. LOH could be demonstrated in the whole
primary tumor
at D13S217 (13q12) and D18S58 (18q21). In three other microsatellite loci [D9S162 (9p22-p21), D10S251 and D10S541 (surrounding the PTEN/MMAC1 gene on 10q23-q24)], clearly recognizable LOH was found in the solid part and in the metastasis, whereas the tubular component demonstrated only a slight decrease of the same allele. No mutation or methylation of the p16 gene or alteration of the PTEN/MMAC1 gene could be found. Nevertheless, our results provoke a discussion, whether these genetic alterations could be considered as determinants of histologically and prognostically divergent types in EMC.
...
PMID:Epithelial-myoepithelial carcinoma of the parotid gland-evidence of contrasting DNA patterns in two different histological parts. 1271 74
We describe the presentation, management, and clinical outcome of a massive acinic cell
carcinoma of the parotid
gland. The
primary tumor
and blood underwent exome sequencing which revealed deletions in CDKN2A as well as PPP1R13B, which induces p53. A damaging nonsynonymous mutation was noted in EP300, a histone acetylase which plays a role in cellular proliferation. This study provides the first insights into the genetic underpinnings of this cancer. Future large-scale efforts will be necessary to define the mutational landscape of salivary gland malignancies to identify therapeutic targets and biomarkers of treatment failure.
...
PMID:A case report and genetic characterization of a massive acinic cell carcinoma of the parotid with delayed distant metastases. 2365 77
We performed surgical resection for a case of hepatic metastasis of an adenoid cystic
carcinoma of the parotid
gland. A 53-year-old woman underwent parotidectomy for primary adenoid cystic carcinoma in 2004. In 2005, she underwent resection of a local recurrence. However, in 2012, 8 years after
primary tumor
resection, abdominal ultrasonography revealed a hepatic tumor in the lateral segment, for which we performed laparoscopic partial hepatectomy. The hepatic tumor was histologically diagnosed as a hepatic metastasis of the adenoid cystic
carcinoma of the parotid
gland. At 8 postoperative months, no further recurrence was observed.
...
PMID:[A case of hepatic resection of liver metastasis 8 years after resection of an adenoid cystic carcinoma of the parotid gland]. 2439 46